GL1X · GenesisL1 explorer

MolNFT v1 · #254805 · protein

AlphaFold monomer V2.0 prediction for major vault protein (Q9EQK5)

Q9EQK5: “AlphaFold monomer V2.0 prediction for major vault protein (Q9EQK5)”. 6 pockets (best druggability 0.67). MolNFT v1 #254805 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

Accession
Q9EQK5
Type
protein
Length
861 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x8A26B6CB9a581dc8b6062B396e50E819766d0D4a
Molecule
Major vault protein
UniProt
Q9EQK5
Pockets
6 · best druggability 0.67

Structure

1 distinct chain · 27% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMajor vault proteinprotein86127% helix, 34% strandQ9EQK5

Pockets

6 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13410.670.8142empty
2960.460.8015empty
3570.370.7922empty
4650.340.7712empty
5580.280.7313empty

Compared structures

  • 3GF5 · Crystal structure of the P21 R1-R7 N-terminal domain of murine mvp · an experimental structure of the same protein · chain A against B, TM-score 0.43
  • 3GF5 · Crystal structure of the P21 R1-R7 N-terminal domain of murine MVP · an experimental structure of the same protein · chain A against B, TM-score 0.43
  • 3GNG · P21B crystal structure of R1-R7 of murine mvp · an experimental structure of the same protein · chain A against A, TM-score 0.42
  • 3GNG · P21B crystal structure of R1-R7 of Murine MVP · an experimental structure of the same protein · chain A against A, TM-score 0.42
  • 3GNF · P1 Crystal structure of the N-terminal R1-R7 of murine MVP · an experimental structure of the same protein · chain A against B, TM-score 0.41
  • 3GNF · P1 crystal structure of the N-terminal R1-R7 of murine mvp · an experimental structure of the same protein · chain A against B, TM-score 0.41

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.